Sol-Gel Technologies (SLGL) Research & Development (2017 - 2026)
Sol-Gel Technologies (SLGL) reported Research & Development of $2.8 million for Q1 2026, down 68.49% year-over-year from $8.8 million in Q1 2025, and down 22.27% quarter-over-quarter from $3.6 million in Q4 2025.
Sol-Gel Technologies (SLGL) Research & Development (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Research & Development data on file, last reported at $2.8 million in Q1 2026.
- Research & Development for Q1 2026 came in at $2.8 million, down 68.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.7 million (down 21.38% YoY), and the FY2025 annual result was $22.8 million, up 28.09% from the prior year.
- Research & Development slipped to $2.8 million in Q1 2026 per SLGL's latest filing, from $3.6 million in the prior quarter.
- Over five years, Research & Development peaked at $9.4 million in Q1 2023 and troughed at $2.0 million in Q3 2022.
- A 5-year average of $4.7 million and a median of $4.6 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2026: Research & Development surged 132.21% in 2023, then plunged 68.49% in 2026.
- A 5-year view of Research & Development shows it stood at $4.2 million in 2022, then slipped by 1.09% to $4.2 million in 2023, then gained by 24.6% to $5.2 million in 2024, then plunged by 31.04% to $3.6 million in 2025, then retreated by 22.27% to $2.8 million in 2026.
- Business Quant data shows SLGL's Research & Development at $2.8 million in Q1 2026, $3.6 million in Q4 2025, and $5.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 8.84 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | 2.44 Mn |
| Mar 31, 2024 | 5.35 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Sep 30, 2023 | 4.67 Mn |
| Jun 30, 2023 | 5.31 Mn |
| Mar 31, 2023 | 9.39 Mn |
| Dec 31, 2022 | 4.22 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 2.38 Mn |
| Mar 31, 2022 | 4.04 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 5.99 Mn |
| Jun 30, 2021 | 6.93 Mn |